Skip to main content
ConductScienceScienceDex

Libin Xu

From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.

FY2025 NIH rank #6,628
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Mentor

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10890127Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#6,628
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Libin Xu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Libin Xu as a PI. Multi-PI records show the full award amount for context.

  • 5R01ES035021-02R01Contact PI
    Impact of benzalkonium chloride on gut microbiome and gut-liver interactions
    University of Washington · Pharmacology (NIH department code)
    $648.7K
    award amount
  • 5R01AI136979-07R01Co-investigator
    Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA
    University of Washington · Pharmacology (NIH department code)
    $550.2K
    award amount
  • 5R01ES031927-05R01Contact PI
    Interactions between metabolism, transport, and toxicity of benzalkonium chlorides
    University of Washington · Pharmacology (NIH department code)
    $463.6K
    award amount
  • 1T32GM159560-01T32Co-investigator
    Drug Action, Metabolism and Kinetics Training Grant
    University of Washington · Pharmacology (NIH department code)
    $352.6K
    award amount

Award organization

Organizations that administered FY2025 awards listing Libin Xu as a PI.

FY2025 award administered by University of Washington (WA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Washington
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4991
  6. 2024
    Entered Top 25% Nationally
    Ranked #4991
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Libin Xu.

Brian James Werth
University of Washington
3
shared awards
William M Atkins
University of Washington
2
shared awards
Dan Fu
University of Washington
1
shared award

Explore further

Find collaborators for Libin Xu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →